Announced
Completed
Synopsis
Biotechnology Value Fund, a San Francisco-based private investment partnership specializing in fundamentally-driven public biotechnology investments, completed the $60m investment in Verastem, an American pharmaceutical company that develops medicines to treat certain cancers.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.